Physician profile
Eric Daniel Scripture
NPI 1013367119
$1,653.72
in general payments reported to CMS, 2019-2025
20 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $143 · 2021: $168 · 2022: $364 · 2023: $164 · 2024: $310 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $288.31 | 2019-2024 | Clareon |
| Genentech USA, INC. | $213.34 | 2021-2024 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $186.30 | 2019-2025 | Eylea, Eylea Hd |
| Glaukos Corporation | $180.54 | 2020-2025 | Idosetr, Istent Infinite |
| Allergan, INC. | $128.40 | 2019-2021 | |
| Rxsight INC | $116.16 | 2022-2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Novartis Pharmaceuticals Corporation | $91.91 | 2020-2023 | |
| Harrow Eye, LLC | $81.60 | 2024-2025 | Iheezo, Triesence |
| Coherus Oncology, INC. | $58.18 | 2023-2024 | |
| Abbvie INC. | $54.30 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.41 | 2021 | |
| Mallinckrodt Hospital Products INC. | $37.90 | 2024 | Acthar |
| Biogen, INC. | $34.60 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $25.97 | 2022-2023 | Vyzulta, Miebo |
| Sandoz INC. | $23.41 | 2025 | Cimerli |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $21.68 | 2024 | Tecnis Simplicity |
| Apellis Pharmaceuticals, INC. | $18.33 | 2024 | Syfovre |
| New World Medical,INC. | $16.95 | 2021 | |
| Aerie Pharmaceuticals, INC. | $16.19 | 2021 | |
| Omeros Corporation | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Scripture listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.